Mavefund EN
CHEMED CORP logo

CHEMED CORP

CHE
Letzter Kurs (USD) US$522.00
Marktkapitalisierung (USD) US$7.2b
Kursänderung 12 Monate 13.99%
Loading the 12-month Mave Thesis and 1-month news signal

Branchen- und Sektorvergleich sowie weitere Research-Alternativen

Vergleich ansehen
Universal Health Services IncUHS Vergleich DaVita HealthCare Partners IncDVA Vergleich Tenet HealthcareTHC Vergleich Zoetis IncZTS Vergleich
Überblick Ergebnisbericht Kursverlauf Nachrichten Wettbewerber Gewinn je Aktie Eigenkapitalrendite Nettomarge Aktienrückkäufe Verschuldung Finanzberichte Finanzkennzahlen
Start Heute Aktien Watchlist

CHEMED CORP Überblick

Branche: Medical Care Facilities

Sektor: Healthcare

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in two segments, VITAS and Roto-Rooter. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees. The company was incorporated in 1970 and is headquartered in Cincinnati, Ohio. Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in two segments, VITAS and Roto-Rooter. It offers plumbing,

Research-Überblick

Letztes Berichtsdatum 2026-07-28

Diese Mavefund-Research-Seite bündelt geprüfte Informationen zu CHEMED CORP (CHE): Unternehmensprofil, Kursverlauf, verknüpfte Primärquellen, verfügbare Finanzberichte, Research-Signale und zu prüfende Risiken.

Börsennotierung
CHE · NYSE · MIC XNYS
Land
United States
Handelswährung
USD
Branche
Medical Care Facilities
Finanzdaten
Jahres- und Zwischenabschlüsse verfügbar
Letzte Primärquelle
SEC EDGAR · veröffentlicht 2026-07-28
Primärquellen

Die Abdeckung wird automatisch aktualisiert und erst nach einer Datenintegritätsprüfung veröffentlicht. Nur Research-Unterstützung; keine persönliche Anlageberatung.

Mavefund ordnet die verfügbaren Fundamentaldaten, Bewertungskennzahlen und Risikofaktoren von CHEMED CORP für einen nachvollziehbaren Research-Prozess ein.

Score

Veröffentlichte Ergebnisse

Was das Unternehmen berichtet hat – mit kompakter Quellenangabe.

Veröffentlicht Jul 28, 2026

Quarterly result summary

Revenue was $443.3M (reported); EPS was $6.06 (reported).

Revenue $443.3M reported
EPS $6.06 reported
Operating income $89.2M +31% YoY
Net income $67.7M +29% YoY

Was sich verändert hat

  • Revenue reported to $443.3M; EPS reported to $6.06.
  • Operating income +31% YoY to $89.2M.
  • Net income +29% YoY to $67.7M.

Guidance / outlook

No formal outlook was extracted from this filing excerpt. Open the source document to review full management commentary.

Earnings release Bericht öffnen

Source: SEC EDGAR company-filed earnings materials. Dates and source identifiers are retained for verification; review the original filing before relying on extracted report details.

Weitere aktuelle Ergebnisunterlagen
SEC filing 10-Q Jul 31, 2026 SEC filing 8-K Jul 28, 2026 SEC filing 10-Q Apr 28, 2026 SEC filing 8-K Apr 23, 2026 Earnings release Earnings release Apr 23, 2026 SEC filing FORM 10-K Feb 27, 2026 SEC filing 8-K Feb 25, 2026 Earnings release Earnings release Feb 25, 2026 SEC filing 10-Q Oct 31, 2025 SEC filing 8-K Oct 28, 2025 Earnings release Earnings release Oct 28, 2025

Geprüfte Signal-Evidenz

Aktuelle Nachrichten

Unternehmensrelevante Artikel aus Quellen, die die Relevanz- und Zuverlässigkeitsprüfung des Mave Signals bestehen.

Gewinn je Aktie

Score 3.00/5
CHEMED CORP boasts a high score, as its Earnings Per Share (EPS) has demonstrated consistent growth over the past six years. Notable counterparts in the sector with high scores includes Zoetis Inc IQVIA Holdings Inc Agilent Technologies Inc
In Medical Care Facilities industry , Universal Health Services Inc , DaVita HealthCare Partners Inc , Tenet Healthcare are companies with high ratings.

Eigenkapitalrendite

Score 3.64/5
CHEMED CORP stands out with a superior score in the Return on Equity (ROE) section, surpassing the sector median value and showcasing its strong performance in this metric. The top companies in the same sector include Zoetis Inc IQVIA Holdings Inc Agilent Technologies Inc
CHEMED CORP CHE US$7.2b
Zoetis Inc ZTS US$31.9b
IQVIA Holdin... IQV US$34.8b
Agilent Tech... A US$37.9b

Nettomarge

Score 4.74/5
CHEMED CORP commands a high score, propelled by its net margin consistently outpacing the sector median value and exhibiting continuous growth in recent six years; noteworthy counterparts in the sector, boasting similarly high scores, include Zoetis Inc IQVIA Holdings Inc Agilent Technologies Inc
CHEMED CORP CHE US$7.2b
Zoetis Inc ZTS US$31.9b
IQVIA Holdin... IQV US$34.8b
Agilent Tech... A US$37.9b

Aktienrückkäufe

In Medical Care Facilities industry , Universal Health Services Inc , DaVita HealthCare Partners Inc , Tenet Healthcare are companies with high ratings.

Verschuldung

Score 2.39/5
CHEMED CORP registers a lower score in the category as a result of its elevated leverage ratio over the past six years compared to the sector median value. Conversely, other companies in the same sector, including Zoetis Inc IQVIA Holdings Inc Agilent Technologies Inc have achieved high scores.
CHEMED CORP CHE US$7.2b
Zoetis Inc ZTS US$31.9b
IQVIA Holdin... IQV US$34.8b
Agilent Tech... A US$37.9b

Finanzberichte

Vom Unternehmen veröffentlichte Berichtsdaten, strukturiert und mit der Originalquelle verknüpft.

Berichtswährung
Geprüfte, quellenverknüpfte Finanzberichte werden geladen, sobald dieser Abschnitt sichtbar wird.

Quellendetails werden mit den Berichtsdaten geladen. Die Werte sind standardisierte Unternehmensangaben zur Research-Unterstützung, keine persönliche Anlageberatung.

Finanzkennzahlen

Jährlich Quartalsweise

Finanzen
Profitabilität
Wachstum
Cashflow
Finanzielle Stabilität
Effizienzkennzahlen

CHEMED CORP logo

CHEMED CORP

US$522.00

US$401.19

-23.3% vs price

US$7.2b

-3.51%

13.99%